8-K
Current Report
Avalo Therapeutics, Inc. Filed Acc 0001104659-15-071601
Material agreement · Bylaws or fiscal year change
- Item 1.01 Entry into a material definitive agreement
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading a13-26520_188k.htm…